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Sir
With a research interest in angiogenesis and antiangiogenesis
(Beranek, 1988), I have read the article by Yudoh et al (2001)
concerning microvessel density (MVD) and the concentration of
vascular endothelial growth factor (VEGF) in soft tissue sarcomas.
The authors have found that no signiﬁcant correlation exists
between MVD and the concentration of VEGF in the tumours
and that increased VEGF concentration in tumours and not
MVD is a negative prognostic factor for the disease outcome. This
is an unexpected result deserving further discussion because VEGF
is of central importance in practically all cases of physiologic and
pathologic angiogenesis (Senger, 2001).
Yudoh et al (2001) have determined MVD by the immuno-
positivity of endothelial cells for Factor VIII-related antigen. In
their Figure 1B, numerous blood vessels are seen. A majority
of them manifest a feature which the original authors over-
looked: their walls are thick and manifest the immunopositivity
which is not limited to their most internal cells but extends
across the vessel wall, implying that these walls are lined by
more than one layer of endothelial cells. This phenomenon
may be explained by a dedifferentiation of endothelial cells
induced by angiogenesis (Beranek, 1988). Dedifferentiated
endothelial cells, having lost their polarity and contact inhibition,
are able to form hyperplastic capillary sprouts composed of
several layers of endothelial cells (Beranek, 1988). These sprouts
have the capacity to develop into different vascular structures:
(a) into more or less ectatic capillaries lined by one layer of
endothelial cells; (b) into hyperplastic capillaries lined by more
than one layer of endothelial cells (Yudoh et al, 2001, Figure
1B); (c) into muscle vessels by the transdifferentiation of periph-
eral undifferentiated endothelial cells into smooth muscle cells
(Beranek, 1998), and (d) into endothelial glomeruloid formations
by the death of some and the redifferentiation of other undiffer-
entiated endothelial cells (Beranek, 1991, Figure 1).
Recently, Sundberg et al (2001) injected adenoviral vectors
expressing murine VEGF intradermally into mouse ears and
provoked a formation of endothelial glomeruloid bodies, conﬁrm-
ing thereby experimentally the hypothesis that vascular endothelial
cells dedifferentiate during angiogenesis and are able to form
hyperplastic vascular structures lined by more than one layer of
endothelial cells. In order to quantify angiogenesis one must, there-
fore, take into consideration not only MVD but also the
endothelial hyperplasia of newly formed vessels (Beranek, 2001).
In this case, it is quite probable that VEGF tumour concentration
will correlate with morphologic manifestations of tumour angio-
genesis and that both these factors will be implicated in the
disease prognosis. Yudoh et al (2001) divided their patients in
groups with or without local recurrence and with or without
metastasis. It would be interesting to know whether the groups
without local recurrence and without metastasis manifest less
endothelial hyperplasia than their counterparts.
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